Publications

5808 Results

Association of sex and adverse events (AEs) of adjuvant chemotherapy (ACT) in early stage colon cancer (CC): A pooled analysis of 28,636 patients (pts) in the ACCENT database

Authors
AD Wagner;A Grothey;T Andre;J Dixon;N Wolmark;D Haller;CJ Allegra;E VanCutsem;T George;A DeGramont;S Alberts;C Twelves;M O'Connell;L Saltz;C Blanke;G Francini;R Kerr;R Goldberg;G Yothers;Q Shi
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr 3603); ASCO 2018 Annual Meeting (June 1-5, 2018, Chicago, IL), poster session
Year
2018
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415)

CA15-3/MUC1 in CCTG MA.32: A phase III RCT of the effect of metformin vs. placebo on invasive disease free and overall survival in early stage breast cancer

Authors
R Dowling;W Parulekar;K Gelmon;L Shepherd;S Virk;M Ennis;F Mao;J Ligibel;D Hershman;R Rastogi;I Mayer;T Hobday;J Lemieux;AM Thompson;M Rabaglio-Poretti;T Whelan;V Stamboic;B Chen;P Goodwin
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr 557); ASCO Annual Meeting (June 1-5, 2018, Chicago, IL), poster session
Year
2018
Research Committee(s)
Breast

Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) study (NRG- GI004/SWOG-S1610): A randomized phase III study of mFOLFOX6/ bevacizumab combination chemotherapy with or without atezolizumab or atezolizumab monotherapy in the first-line treatment of patients with deficient DNA mismatch repair (dMMR) metastatic colorectal cancer

Authors
J Lee;G Yothers;SA Jacobs;H Sanoff;D Cohen;K Guthrie;NL Henry;P Ganz;PC Lucas;C Allegra;C Blanke;N Wolmark;H Hochster;TJ George;M Overman
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr TPS3615); ASCO Annual Meeting (June 1-5, 2018, Chicago, IL), poster session
Year
2018
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/NRG-GI004

Phase III, randomized, double blind, placebo-controlled trial of sorafenib in desmoid tumors (Alliance A091105)

Authors
M Gounder;MR Mahoney;BA Van Tine;V Ravi;S Attia;H Deshpande;A Gupta;M Milhem;R Conry;S Movva;M Pishvaian;J Crawford;T Sabagh;R Maki;W Tapp;R Lefkowitz;N Agaram;JJ Wright;A Dueck;GK Schwartz
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr 11500); ASCO Annual Meeting (June 1-5, 2018, Chicago, IL), oral
Year
2018

Reduced Risk of Prostate Cancer With 5a-Reductase Inhibitors. [Editorial]

Authors
IM Thompson;P Goodman;C Tangen
Journal / Conference
Journal of the National Cancer Institute Nov 1;110(11):1159-1160; Mar 14. doi: 10.1093/jnci/djy038. [Epub ahead of print]
Year
2018
Research Committee(s)
Cancer Control
PMID
PMID29547919
PMC
PMCIDPMC6454440
Study Number(s)
SWOG-9217

Chemoprevention in Prostate Cancer: Current Perspective and Future Directions [Review]

Authors
J Rivero;IM Thompson;M Liss;D Kaushik
Journal / Conference
Cold Spring Harbor Perspectives in Medicine Oct 1;8(10); 2018 Jan 8 [Epub ahead of print]
Year
2018
Research Committee(s)
Cancer Control
PMID
PMID29311128
PMC
PMC6169981
Study Number(s)
SWOG-9217

The Breast Cancer Weight Loss (BWEL) trial: Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early-stage breast cancer (Alliance A011401)

Authors
J Ligibel;W Barry;C Alfano;D Hershman;M Irwin;M Neuhouser;C Thomson;L Delahanty;E Frank;P Spears;E Paskett;JO Hopkins;V Bernstein;V Stearns;JR White;T Wadden;PJ Goodwin;L Carey;A Partridge;E Winer
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr TPS598); ASCO Annual Meeting (June 1-5, 2018, Chicago), poster
Year
2018
Research Committee(s)
Breast
Study Number(s)
CTSU/A011401

Low free testosterone and prostate cancer risk: a collaborative analysis of 20 prospective studies

Authors
EL Watts;P Appelby;A Perez-Cornago;H Bas Bueno-de-Mesquita;J Chan;C Chen;al et
Journal / Conference
European Urology Nov;74(5):585-594; Aug 1 [Epub ahead of print]
Year
2018
Research Committee(s)
Cancer Control, Prevention, Screening, and and Surveillance
PMID
PMID30077399
PMC
PMC6195673
Study Number(s)
SWOG-9217

Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials

Authors
S Ailawadhi;S Jacobus;R Sexton;A Stewart;A Dispenzieri;M Hussein;JA Zonder;J Crowley;A Hoering;B Barlogie;R Orlowski;S Rajkumar
Journal / Conference
Blood Cancer Journal, Jul 6;8(7):67
Year
2018
Research Committee(s)
Cancer Survivorship and Myeloma
PMID
PMID29980678
PMC
PMC6035273
Study Number(s)
S0204, S0232, SWOG-9321

Value of Anti-Cancer Drugs in SWOG Phase III Clinical Trials: Evidence from Multiple Evaluation Mechanisms

Authors
V Nghiem;R Vaidya;M Banegas;D Hershman;J Unger
Journal / Conference
AcademyHealth Annual Research Meeting (June 23-26, 2018, Seattle, WA), poster #B-335
Year
2018
Research Committee(s)
Breast, Cancer Care Delivery, Gastrointestinal, Genitourinary, Gynecologic, Leukemia, Lung, Lymphoma, Melanoma, and Myeloma
Study Number(s)
S0003, S0008, S0012, S0106, S0124, S0200, S0205, S0226, S0232, S0421, SWOG-8501 (INT-0051), SWOG-8612, SWOG-8691 (INT-0073), SWOG-8692 (INT-0075), SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891), SWOG-8794, SWOG-8795 (INT-0094) (EST-1888), SWOG-8812, SWOG-8814, SWOG-8894 (INT-0105) (EST-2889), SWOG-8949, SWOG-9028, SWOG-9031, SWOG-9032, SWOG-9133, SWOG-9210, SWOG-9308, SWOG-9313, SWOG-9321, SWOG-9333, SWOG-9346, SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415), SWOG-9420, SWOG-9509, S9623, S9701, S9916